[Pharmacological studies on DL-1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide, a new antitumor agent (author's transl)].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology*; D011817:Rabbits; D012890:Sleep / Q000187:drug effects
D000970:Antineoplastic Agents; D010880:Piperidines; C025056:1-(gamma-chloropropyl)-2-chloromethylpiperidine